Congenital haemolytic anaemia associated with adenylate kinase deficiency. 1994

A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
Institute of Haematology, Chaim Sheba Medical Centre, Tel-Aviv University, Israel.

Chronic haemolytic anaemia associated with adenylate kinase (AK) deficiency is very rare and only seven cases in five families have been described. We present six children of one family who are deficient of this enzyme and in three of them a combined G6PD deficiency was found. AK deficiency was transmitted by an autosomal recessive gene and heterozygous state was not accompanied by disease, whereas homozygously affected individuals present a congenital chronic non-spherocytic haemolytic anaemia with haemoglobin levels of 8-9 g/dl. Patients also deficient in G6PD suffer from a more severe haemolytic anaemia with haemoglobin levels around 6 g/dl. The AK-deficient children are also mentally retarded. Splenectomy performed in five of the six patients resulted in complete remission of the haemolytic process.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005952 Glucose-6-Phosphatase An enzyme that catalyzes the conversion of D-glucose 6-phosphate and water to D-glucose and orthophosphate. EC 3.1.3.9. Glucosephosphatase,Glucose 6-Phosphatase,Glucose-6-Phosphate Phosphohydrolase,Glucose 6 Phosphatase
D005953 Glycogen Storage Disease Type I An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood. Glucose-6-Phosphatase Deficiency,Glucosephosphatase Deficiency,Glycogenosis 1,Hepatorenal Glycogen Storage Disease,von Gierke Disease,Deficiency, Glucosephosphatase,Gierke Disease,Gierke's Disease,Glycogen Storage Disease 1 (GSD I),von Gierke's Disease,Deficiencies, Glucose-6-Phosphatase,Deficiencies, Glucosephosphatase,Deficiency, Glucose-6-Phosphatase,Disease, Gierke,Disease, Gierke's,Disease, von Gierke,Disease, von Gierke's,Gierkes Disease,Glucose 6 Phosphatase Deficiency,Glucose-6-Phosphatase Deficiencies,Glucosephosphatase Deficiencies,von Gierkes Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000263 Adenylate Kinase An enzyme that catalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. EC 2.7.4.3. Myokinase,AMP Kinase,ATP-AMP Phosphotransferase,ATP-AMP Transphosphorylase,Adenylokinase,ATP AMP Phosphotransferase,ATP AMP Transphosphorylase,Kinase, AMP,Kinase, Adenylate,Phosphotransferase, ATP-AMP,Transphosphorylase, ATP-AMP
D000745 Anemia, Hemolytic, Congenital Hemolytic anemia due to various intrinsic defects of the erythrocyte. Anemia, Hemolytic, Hereditary,Congenital Hemolytic Anemia,Hemolytic Anemia, Congenital,Hemolytic Anemia, Hereditary,Hereditary Hemolytic Anemia,Anemia, Congenital Hemolytic,Anemia, Hereditary Hemolytic,Anemias, Congenital Hemolytic,Anemias, Hereditary Hemolytic,Congenital Hemolytic Anemias,Hemolytic Anemias, Congenital,Hemolytic Anemias, Hereditary,Hereditary Hemolytic Anemias

Related Publications

A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
January 1964, Vox sanguinis,
A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
August 1963, Acta haematologica,
A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
December 1967, The New Zealand medical journal,
A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
July 1963, Lancet (London, England),
A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
June 1970, La Presse medicale,
A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
January 1971, Folia medica Neerlandica,
A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
January 1979, British journal of haematology,
A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
January 1979, British journal of haematology,
A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
January 1968, Acta paediatrica Academiae Scientiarum Hungaricae,
A Toren, and F Brok-Simoni, and I Ben-Bassat, and F Holtzman, and M Mandel, and Y Neumann, and B Ramot, and G Rechavi, and G Kende
December 1997, British journal of haematology,
Copied contents to your clipboard!